Benefit-Risk Considerations for Product Quality Assessments
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 9, 2022
May 10, 2022
dd4547d7-4ac9-437a-8d9b-b88b234da4bc
Related Documents
Establishing Impurity Specifications for Antibiotics
Guidance DocumentApril 20, 2026Center for Drug Evaluation and Research
Quality Considerations for Topical Ophthalmic Drug Products
Guidance DocumentDecember 27, 2023Center for Drug Evaluation and Research
How To Obtain a Covered Product Authorization
Guidance DocumentSeptember 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.